急性心肌梗死生化标志物的研究进展

Research Advancements for Biomarkers Used in Acute Myocardial Infarction

急性心肌梗死是临床常见的危重疾病,血液中生化标志物的测定是反映心肌损伤的重要手段之一。生化标志物凭其高度的敏感性及特异性,在急性心肌梗死的诊断、危险分层及评估预后中发挥了非常重要的作用。目前已有越来越多的心肌梗死生化标志物在临床中得到应用。现就急性心肌梗死损伤生化标志物的最新研究进展做一综述。

Acute myocardial infarction （AMI） is a clinical disease. The measurement of biochemical markers in the blood is one of the most important methods to identify myocardial injury. Biochemical markers with their high specificity and sensitivity play an important role in diagnosis, risk stratification and prognosis of patients with AMI. Recently, many biomarkers for AMI have been used in the clinic. This article reviews current research in this field.